KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 92 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $5,849,000 | +11.9% | 78,006 | +12.4% | 0.01% | +28.6% |
| Q2 2015 | $5,226,000 | +94.3% | 69,388 | +29.4% | 0.01% | +75.0% |
| Q1 2015 | $2,690,000 | +68.5% | 53,627 | +16.6% | 0.00% | +100.0% |
| Q4 2014 | $1,596,000 | +3.7% | 46,011 | -2.0% | 0.00% | -33.3% |
| Q3 2014 | $1,539,000 | +5.4% | 46,967 | +23.5% | 0.00% | +50.0% |
| Q2 2014 | $1,460,000 | +23.7% | 38,026 | +28.2% | 0.00% | 0.0% |
| Q1 2014 | $1,180,000 | +17.4% | 29,656 | +10.0% | 0.00% | 0.0% |
| Q4 2013 | $1,005,000 | +3.0% | 26,971 | +28.0% | 0.00% | 0.0% |
| Q3 2013 | $976,000 | +105.9% | 21,076 | +21.5% | 0.00% | +100.0% |
| Q2 2013 | $474,000 | – | 17,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |